Clinical Trials of Dendritic Cell Therapies for Cancer: Symposium and Webinar
Tell a Friend About This EventTell a Friend
Clinical Trials of Dendritic Cell Therapies for Cancer: Symposium and Webinar

Biotech's Bumpy Road to the Market Symposium & Webinar

10/28/2013 to 10/29/2013
When: 10/28/2013
8:00 AM
Where: The New York Academy of Sciences
7 World Trade Center
250 Greenwich Street, 40th Floor
New York, New York  10007-2157
United States

« Go to Upcoming Event List  

Clinical Trials of Dendritic Cell Therapies for Cancer: Biotech's Bumpy Road to the Market Symposium & Webinar

Date/Time: Monday, October 28, 2013 | 8:00 AM - 5:00 PM

Website: www.nyas.org/DendriticCells

Description:

Dendritic cells (DCs) are the most potent antigen-presenting cells known, with an important role in the development of cancer vaccines. While clinical trials show that dendritic cells vaccines are safe and elicit immunological responses in most patients, few complete tumor remissions have been reported. Because dendritic cells are readily matured ex vivo, strategies to ensure that they access lymphoid tissues and retain an immunostimulatory phenotype are required. Recent FDA approval of the first dendritic cell therapy, Provenge, has helped to establish proof of principle that properly activated DCs can lead to meaningful therapeutic responses. Despite occasional spectacular complete tumor regressions, this therapeutic approach has not been fully realized. This symposium will highlight recent clinical trial results and provide a biotech perspective on the remaining bottlenecks and roadblocks that must be solved in order for DC therapy to be successfully commercialized.

Speakers:

Richard L. Edelson, MD, Yale School of Medicine

Edgar G. Engleman, MD, Stanford University School of Medicine

Thomas Felzmann, MD, Activartis Biotech GmbH, Austria

Lana E. Kandalaft, PharmD, MTR, PhD, University of Pennsylvania

Matthew Lehman, Prima Biomed, Australia

Gregory Lizee, PhD, MD Anderson Cancer Center

Charles A. Nicolette, PhD, Argos Therapeutics Inc.

Sarah J. Schlesinger, MD, The Rockefeller University

Adam Steinman

James B. Trager, PhD, Dendreon Corporation

John S. Yu, MD, Cedars-Sinai Medical Center and Immunocellular Therapeutics, Ltd.

Registration and Webinar Pricing:

Academy Member          $30

Academy Student/Postdoc Member      $15

Nonmember (Academia)             $65

Nonmember (Corporate)             $85

Nonmember (Non-profit)            $65

Nonmember (Student / Postdoc / Resident / Fellow)     $45

Register at www.nyas.org/DendriticCells

Location:

The New York Academy of Sciences

7 World Trade Center

250 Greenwich Street, 40th Floor

New York, NY 10007-2157

www.nyas.org/Directions

Presented by: The New York Academy of Sciences

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.